Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Keros Therapeutics Adds Veteran Finance Leader to Board
Keros Therapeutics (KROS) has appointed Charles Newton, former CFO of Lyell Immunopharma and a veteran healthcare investment banker, as a Class III director, effective March 9, 2026. Newton will also join the Compensation and Audit Committees, bringing extensive financial and capital markets expertise to support Keros’s clinical pipeline. This appointment coincides with long-serving director Carl Gordon stepping down from the board.